全文获取类型
收费全文 | 1459篇 |
免费 | 90篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 25篇 |
儿科学 | 81篇 |
妇产科学 | 108篇 |
基础医学 | 163篇 |
口腔科学 | 81篇 |
临床医学 | 136篇 |
内科学 | 319篇 |
皮肤病学 | 15篇 |
神经病学 | 74篇 |
特种医学 | 53篇 |
外科学 | 268篇 |
综合类 | 22篇 |
一般理论 | 1篇 |
预防医学 | 50篇 |
眼科学 | 29篇 |
药学 | 64篇 |
中国医学 | 2篇 |
肿瘤学 | 66篇 |
出版年
2024年 | 3篇 |
2023年 | 14篇 |
2022年 | 16篇 |
2021年 | 50篇 |
2020年 | 24篇 |
2019年 | 56篇 |
2018年 | 42篇 |
2017年 | 45篇 |
2016年 | 67篇 |
2015年 | 57篇 |
2014年 | 57篇 |
2013年 | 84篇 |
2012年 | 105篇 |
2011年 | 75篇 |
2010年 | 53篇 |
2009年 | 51篇 |
2008年 | 93篇 |
2007年 | 116篇 |
2006年 | 101篇 |
2005年 | 86篇 |
2004年 | 47篇 |
2003年 | 41篇 |
2002年 | 47篇 |
2001年 | 30篇 |
2000年 | 19篇 |
1999年 | 35篇 |
1998年 | 10篇 |
1996年 | 5篇 |
1994年 | 5篇 |
1993年 | 4篇 |
1992年 | 13篇 |
1991年 | 14篇 |
1990年 | 10篇 |
1989年 | 5篇 |
1987年 | 6篇 |
1986年 | 4篇 |
1985年 | 3篇 |
1984年 | 7篇 |
1983年 | 3篇 |
1980年 | 3篇 |
1978年 | 4篇 |
1976年 | 2篇 |
1975年 | 2篇 |
1974年 | 3篇 |
1973年 | 7篇 |
1972年 | 4篇 |
1971年 | 6篇 |
1970年 | 4篇 |
1969年 | 3篇 |
1968年 | 3篇 |
排序方式: 共有1557条查询结果,搜索用时 31 毫秒
41.
Ricolinostat (ACY‐1215) induced inhibition of aggresome formation accelerates carfilzomib‐induced multiple myeloma cell death 下载免费PDF全文
Yuko Mishima Loredana Santo Homare Eda Diana Cirstea Neeharika Nemani Andrew J. Yee Elizabeth O'Donnell Martin Karl Selig Steven N. Quayle Shirin Arastu‐Kapur Christopher Kirk Lawrence H. Boise Simon S. Jones Noopur Raje 《British journal of haematology》2015,169(3):423-434
Proteasome inhibition induces the accumulation of aggregated misfolded/ubiquitinated proteins in the aggresome; conversely, histone deacetylase 6 (HDAC6) inhibition blocks aggresome formation. Although this rationale has been the basis of proteasome inhibitor (PI) and HDAC6 inhibitor combination studies, the role of disruption of aggresome formation by HDAC6 inhibition has not yet been studied in multiple myeloma (MM). The present study aimed to evaluate the impact of carfilzomib (CFZ) in combination with a selective HDAC6 inhibitor (ricolinostat) in MM cells with respect to the aggresome‐proteolysis pathway. We observed that combination treatment of CFZ with ricolinostat triggered synergistic anti‐MM effects, even in bortezomib‐resistant cells. Immunofluorescent staining showed that CFZ increased the accumulation of ubiquitinated proteins and protein aggregates in the cytoplasm, as well as the engulfment of aggregated ubiquitinated proteins by autophagosomes, which was blocked by ricolinostat. Electron microscopy imaging showed increased autophagy triggered by CFZ, which was inhibited by the addition of ACY‐1215. Finally, an in vivo mouse xenograft study confirmed a decrease in tumour volume, associated with apoptosis, following treatment with CFZ in combination with ricolinostat. Our results suggest that ricolinostat inhibits aggresome formation, caused by CFZ‐induced inhibition of the proteasome pathway, resulting in enhanced apoptosis in MM cells. 相似文献
42.
Relation of Complementary‐Alternative Medicine use with glomerular filtration rate and depression in patients with chronic kidney disease at predialysis stage 下载免费PDF全文
43.
Meltem Halil Mustafa Cankurtaran Burcu Balam Yavuz Nihal Ozkayar Zekeriya Ulger Didem Sener Dede Ali Shorbagi Yahya Buyukasik Ibrahim Celalettin Haznedaroglu Servet Arogul 《Blood coagulation & fibrinolysis》2005,16(5):349-353
EGb 761 is widely used in the management of mild cognitive impairment in the elderly population. Elucidation of the effects of EGb 761 on primary haemostasis via PFA-100 could represent an important step for better understanding of the haemostatic safety of EGb 761. The purpose of this prospective study is to assess the effects of Ginkgo biloba special extract, EGb 761, on PFA-100 in vitro bleeding time in elderly patients with mild cognitive impairment. A total of 40 elderly patients aged 65-79 years who were referred for geriatric assessment and who were diagnosed as having mild cognitive impairment were included. Patients were started on 80 mg EGb-761 three times daily. The complete set of PFA-100 in vitro bleeding time and coagulation parameters including prothrombin time, activated partial thromboplastin time and International Normalized Ratio were assessed before and on the seventh day of treatment with EGb 761. There was no statistically significant prolongation in PFA-100 in vitro bleeding time or coagulation parameters in patients receiving EGb 761 after 7 days. The data about the safety of EGb 761 from the point of primary haemostasis in our elderly patient population with mild cognitive impairment casts hope for the future management of this 'difficult-to-treat' population with the promising Ginkgo extracts. 相似文献
44.
45.
Eda Ozcelik Sema Uslu Nilufer Erkasap Hadi Karimi 《The Kaohsiung journal of medical sciences》2014,30(6):286-290
Acetaminophen (APAP) is the most commonly reported toxic ingestion in the world. Severe liver injury resulting from overdose or chronic use of APAP remains a significant clinical problem. In recent years, the mechanisms underlying liver injury caused by APAP have become much better understood. We have studied the protective effect of chitosan supplementation against APAP-induced hepatotoxicity with respect to changes in the levels of total and lipid-bound sialic acid in the serum and in the liver tissue and changes in the activity of diagnostic marker enzymes, lipid peroxidation, and ceruloplasmin oxidase enzyme in normal and experimental groups of rats. During the experimental period, chitosan (200 mg/kg body weight per day) was administered to APAP + chitosan-treated rats by oral gavage. Results showed that treatment with APAP induced a significant increase in the serum alanine aminotransferase and alkaline phosphatase activities, in total and lipid-bound sialic acids levels, and in the liver lipid peroxide content. The administration of chitosan significantly prevented APAP-induced alterations in the levels of diagnostic marker enzymes, total sialic acid, lipid-bound sialic acid, and malondialdehyde in the experimental groups of rats. Furthermore, chitosan administration increased the activity of ceruloplasmin oxidase. In conclusion, our results suggest that chitosan has a protective effect on APAP-induced hepatic injury in rats. The study sheds light on the therapeutic potential of chitosan in an APAP-induced hepatotoxicity model. 相似文献
46.
Halil I. Ciftci Nilüfer Bayrak Hatice Yldrm Mahmut Yldz Mohamed O. Radwan Masami Otsuka Mikako Fujita Ama F. Tuyun 《Archiv der Pharmazie》2019,352(12)
Two series of amino‐1,4‐benzoquinones ( AQ1–18 ) based on the structural analogs of plastoquinones were synthesized and the structure–activity relationship against chronic myelogenous leukemia activity was examined. All of the synthesized compounds were tested for their cytotoxic effects on different leukemic cell lines. Of interest, AQ15 exhibited a better selectivity than the reference drug imatinib on cancer cells. Owing to this, AQ15 was selected for a further apoptosis/necrosis evaluation where AQ15 ‐treated K562 cells demonstrated similar apoptotic effects like imatinib‐treated cells at their IC50 values. The inhibitory effects of AQ15 and the other three compounds with various activities against eight tyrosine kinases, including ABL1, were investigated. AQ15 showed weak activity against ABL1, and a correlation was observed between the anti‐K562 and anti‐ABL1 activities. The binding mode of AQ15 into the ATP binding pocket of ABL1 kinase was predicted in silico, showing the formation of some key interactions. In addition, AQ15 was shown to suppress the downstream signaling of BCR‐ABL in K562 cells. Finally, AQ15 obviously cleaved DNA in the presence of an iron(II) complex system, indicating that this can be the major mechanism of its antiproliferative action, whereas the mild inhibition of ABL kinase is just in‐part mechanism of its overall outstanding cellular activity. 相似文献
47.
Eda H Kulig KM Steiner TA Shimada H Patel K Park E Kim ES Borenstein JT Neville CM Keller BT 《Digestive diseases and sciences》2012,57(5):1152-1162
Background
Hepatic stellate cells (HSC) play a major role in the progression of liver fibrosis. 相似文献48.
49.
50.
Gürbüz F Kotan LD Mengen E Sıklar Z Berberoğlu M Dökmetaş S Kılıçlı MF Güven A Kirel B Saka N Poyrazoğlu S Cesur Y Doğan M Ozen S Ozbek MN Demirbilek H Kekil MB Temiz F Onenli Mungan N Yüksel B Topaloğlu AK 《Journal of clinical research in pediatric endocrinology》2012,4(3):121-126
Objective: Normosmic idiopathic hypogonadotropic hypogonadism (nIHH) is characterized by failure of initiation or maintenance of puberty due to insufficient gonadotropin release, which is not associated with anosmia/hyposmia. The objective of this study was to determine the distribution of causative mutations in a hereditary form of nIHH. Methods: In this prospective collaborative study, 22 families with more than one affected individual (i.e. multiplex families) with nIHH were recruited and screened for genes known or suspected to be strong candidates for nIHH. Results: Mutations were identified in five genes (GNRHR, TACR3, TAC3, KISS1R, and KISS1) in 77% of families with autosomal recessively inherited nIHH. GNRHR and TACR3 mutations were the most common two causative mutations occurring with about equal frequency. Conclusions: Mutations in these five genes account for about three quarters of the causative mutations in nIHH families with more than one affected individual. This frequency is significantly greater than the previously reported rates in all inclusive (familial plus sporadic) cohorts. GNRHR and TACR3 should be the first two genes to be screened for diagnostic purposes. Identification of causative mutations in the remaining families will shed light on the regulation of puberty. 相似文献